Index RUT
P/E -
EPS (ttm) -0.18
Insider Own 1.11%
Shs Outstand 62.69M
Perf Week -5.74%
Market Cap 405.37M
Forward P/E -
EPS next Y -0.07
Insider Trans 8.59%
Shs Float 62.54M
Perf Month -6.70%
Income -11.45M
PEG -
EPS next Q -0.02
Inst Own 91.01%
Short Float 16.17%
Perf Quarter -2.73%
Sales 136.72M
P/S 2.96
EPS this Y -2666.67%
Inst Trans 6.53%
Short Ratio 7.57
Perf Half Y -8.03%
Book/sh 2.90
P/B 2.21
EPS next Y 74.03%
ROA -2.55%
Short Interest 10.11M
Perf Year -66.54%
Cash/sh 0.49
P/C 13.20
EPS next 5Y 15.00%
ROE -6.28%
52W Range 4.07 - 19.97
Perf YTD -1.38%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI -3.03%
52W High -67.90%
Beta 1.60
Dividend TTM -
Quick Ratio 0.85
Sales past 5Y 24.30%
Gross Margin 12.52%
52W Low 57.47%
ATR (14) 0.48
Dividend Ex-Date -
Current Ratio 1.35
EPS Y/Y TTM -109.47%
Oper. Margin 10.93%
RSI (14) 44.54
Volatility 7.73% 6.76%
Employees 365
Debt/Eq 1.07
Sales Y/Y TTM -2.82%
Profit Margin -8.37%
Recom 1.50
Target Price 11.67
Option/Short Yes / Yes
LT Debt/Eq 1.06
EPS Q/Q -
Payout 0.00%
Rel Volume 0.38
Prev Close 6.39
Sales Surprise -23.55%
EPS Surprise -140.00%
Sales Q/Q -11.09%
Earnings Dec 07 AMC
Avg Volume 1.34M
Price 6.41
SMA20 -4.43%
SMA50 -8.92%
SMA200 -22.59%
Trades
Volume 511,100
Change 0.31%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-28-23 Initiated
William Blair
Mkt Perform
Mar-14-23 Upgrade
KeyBanc Capital Markets
Sector Weight → Overweight
$20
Dec-08-21 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Mar-17-21 Initiated
RBC Capital Mkts
Outperform
$21
Nov-10-20 Initiated
KeyBanc Capital Markets
Overweight
$12
Dec-10-19 Upgrade
First Analysis Sec
Outperform → Strong Buy
Oct-17-19 Initiated
Stephens
Overweight
$8
Oct-16-19 Initiated
Craig Hallum
Buy
$11
Jun-28-19 Upgrade
Janney
Neutral → Buy
$10
May-09-19 Downgrade
Janney
Buy → Neutral
Apr-10-24 12:46PM
Apr-01-24 03:07PM
Mar-28-24 12:51PM
Mar-21-24 02:27PM
Mar-20-24 07:00AM
12:30PM
Loading…
Mar-14-24 12:30PM
Mar-11-24 07:08PM
Mar-10-24 09:01PM
Mar-07-24 02:59PM
09:05AM
Mar-06-24 11:58PM
04:32PM
04:31PM
Jan-30-24 01:11AM
Dec-19-23 05:01AM
09:35AM
Loading…
Dec-08-23 09:35AM
08:15AM
Dec-07-23 09:54PM
05:51PM
05:40PM
04:42PM
(Associated Press Finance)
04:05PM
Dec-01-23 06:16PM
Nov-30-23 04:05PM
Nov-28-23 09:35AM
Nov-15-23 04:02AM
Nov-08-23 08:05AM
Oct-24-23 07:43AM
Oct-17-23 08:05AM
Sep-26-23 04:05PM
01:01AM
Loading…
Sep-23-23 01:01AM
Sep-08-23 08:27AM
05:47AM
(Thomson Reuters StreetEvents)
Sep-07-23 05:40PM
04:28PM
(Associated Press Finance)
04:05PM
Aug-31-23 04:05PM
Aug-22-23 08:14AM
Jul-31-23 05:14AM
Jul-03-23 06:50AM
Jun-23-23 10:05AM
Jun-22-23 03:36PM
12:10PM
06:03AM
(Thomson Reuters StreetEvents)
02:55AM
Jun-21-23 08:00PM
04:18PM
04:07PM
Jun-14-23 04:05PM
Jun-08-23 07:37AM
07:30AM
Jun-04-23 08:03AM
May-30-23 05:48PM
May-22-23 03:15AM
May-10-23 04:05PM
May-08-23 06:12AM
Apr-26-23 08:00PM
Apr-24-23 03:41PM
(Investor's Business Daily)
Apr-17-23 08:17AM
Apr-12-23 07:07AM
Apr-04-23 08:05AM
Mar-14-23 12:35PM
11:20AM
07:22AM
06:07AM
(Thomson Reuters StreetEvents)
Mar-13-23 05:55PM
04:05PM
Mar-10-23 07:24AM
Mar-06-23 04:05PM
Feb-23-23 10:50AM
Feb-16-23 08:43AM
Feb-14-23 04:33PM
Dec-09-22 01:39PM
07:33AM
Dec-06-22 05:35PM
04:30PM
(Thomson Reuters StreetEvents)
04:05PM
Nov-29-22 04:05PM
Nov-17-22 06:03AM
Nov-16-22 08:05AM
Nov-02-22 04:05PM
Oct-17-22 09:55AM
Oct-10-22 08:30AM
Oct-05-22 06:47AM
Sep-27-22 04:05PM
Sep-22-22 08:05AM
Sep-08-22 06:31AM
Sep-07-22 04:05PM
Sep-06-22 11:00PM
05:25PM
04:30PM
(Thomson Reuters StreetEvents)
04:05PM
Sep-01-22 08:05AM
Aug-30-22 04:05PM
Aug-18-22 12:42PM
Aug-02-22 09:11PM
Jun-30-22 07:31AM
03:00AM
Jun-29-22 04:05PM
Jun-22-22 04:05PM
Avid Bioservices, Inc. engages in clinical and commercial manufacturing of biologics. It focuses on the biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and pharmaceutical companies. It specializes in clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions and support. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Kwietniak Matthew R. Chief Commercial Officer Jan 12 '24 Sale 6.77 274 1,855 19,829 Jan 12 07:34 PM Hart Daniel R Chief Financial Officer Jan 10 '24 Sale 6.17 2,408 14,857 79,305 Jan 11 07:36 PM Ziebell Mark R V. P., General Counsel Jan 10 '24 Sale 6.17 1,346 8,305 63,269 Jan 11 07:39 PM Kwietniak Matthew R. Chief Commercial Officer Jan 10 '24 Sale 6.17 1,060 6,540 19,434 Jan 11 07:37 PM Richieri Richard A. Chief Operations Officer Jan 10 '24 Sale 6.17 1,055 6,509 25,625 Jan 11 07:38 PM Richieri Richard A. Chief Operations Officer Jan 10 '24 Sale 6.17 116 716 5,208 Jan 11 07:38 PM Hancock Richard B Director Dec 15 '23 Buy 5.86 23,000 134,734 78,760 Dec 18 07:31 PM Hancock Richard B Director Dec 13 '23 Buy 5.21 38,803 202,036 117,563 Jan 10 07:56 PM Kwietniak Matthew R. Chief Commercial Officer Oct 12 '23 Sale 9.19 255 2,344 17,961 Oct 13 06:00 PM Hart Daniel R Chief Financial Officer Oct 10 '23 Sale 9.20 2,040 18,767 75,081 Oct 11 07:58 PM Ziebell Mark R V. P., General Counsel Oct 10 '23 Sale 9.20 1,141 10,497 60,515 Oct 11 07:59 PM Kwietniak Matthew R. Chief Commercial Officer Oct 10 '23 Sale 9.20 970 8,924 17,546 Oct 11 07:58 PM Richieri Richard A. Chief Operations Officer Oct 10 '23 Sale 9.20 894 8,224 23,276 Oct 11 07:59 PM Richieri Richard A. Chief Operations Officer Oct 10 '23 Sale 9.20 112 1,030 4,177 Oct 11 07:59 PM Carleone Joseph Director Sep 21 '23 Buy 9.53 20,000 190,696 93,956 Sep 22 12:51 PM Green Nicholas Stewart President & CEO Jul 31 '23 Sale 12.99 19,519 253,552 145,844 Aug 01 07:29 PM Richieri Richard A. Chief Operations Officer Jul 13 '23 Sale 13.40 2,734 36,636 4,035 Jul 14 07:07 PM Kwietniak Matthew R. Chief Commercial Officer Jul 12 '23 Sale 13.61 252 3,430 15,984 Jul 13 07:27 PM Ziebell Mark R V. P., General Counsel Jul 11 '23 Sale 13.86 5,015 69,505 58,449 Jul 12 07:38 PM Hart Daniel R Chief Financial Officer Jul 11 '23 Sale 13.86 3,763 52,153 71,380 Jul 12 07:37 PM Richieri Richard A. Chief Operations Officer Jul 11 '23 Sale 13.86 1,420 19,680 21,659 Jul 12 07:37 PM Richieri Richard A. Chief Operations Officer Jul 11 '23 Sale 13.86 122 1,691 6,769 Jul 12 07:37 PM Green Nicholas Stewart President & CEO Jul 10 '23 Sale 13.77 7,530 103,691 127,863 Jul 11 08:13 PM Hart Daniel R Chief Financial Officer Jul 10 '23 Sale 13.77 1,269 17,475 64,420 Jul 11 08:14 PM Ziebell Mark R V. P., General Counsel Jul 10 '23 Sale 13.77 687 9,460 49,173 Jul 11 08:15 PM Richieri Richard A. Chief Operations Officer Jul 10 '23 Sale 13.77 510 7,023 19,033 Jul 11 08:15 PM Kwietniak Matthew R. Chief Commercial Officer Jul 10 '23 Sale 13.77 477 6,569 15,567 Jul 11 08:14 PM Richieri Richard A. Chief Operations Officer Jul 10 '23 Sale 13.77 54 744 6,602 Jul 11 08:15 PM Ziebell Mark R V. P., General Counsel Jun 30 '23 Sale 13.49 1,280 17,267 46,975 Jun 30 08:13 PM Green Nicholas Stewart President & CEO Jun 29 '23 Sale 12.70 40,856 518,928 120,067 Jun 30 08:11 PM Hart Daniel R Chief Financial Officer Jun 29 '23 Sale 12.70 6,884 87,436 61,141 Jun 30 08:12 PM Kwietniak Matthew R. Chief Commerical Officer Jun 29 '23 Sale 12.70 3,947 50,128 14,067 Jun 30 08:12 PM Richieri Richard A. Chief Operations Officer Jun 29 '23 Sale 12.70 2,758 35,030 17,163 Jun 30 08:12 PM Ziebell Mark R V. P., General Counsel Jun 29 '23 Sale 12.70 2,377 30,191 48,255 Jun 30 08:13 PM Hancock Richard B Director Jun 06 '23 Option Exercise 4.53 12 54 39,146 Jun 08 07:45 PM Hancock Richard B Director Jun 06 '23 Sale 16.37 5,000 81,838 39,134 Jun 08 07:45 PM Ziebell Mark R V. P., General Counsel May 01 '23 Option Exercise 9.87 25,000 246,750 65,119 May 02 07:44 PM Hancock Richard B Director May 01 '23 Option Exercise 4.67 5,000 23,350 44,134 May 02 07:43 PM Ziebell Mark R V. P., General Counsel May 01 '23 Sale 17.91 25,000 447,853 40,119 May 02 07:44 PM Hancock Richard B Director May 01 '23 Sale 17.92 5,000 89,601 39,134 May 02 07:43 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite